PATENT CLAIM ANALYSIS

Application Number: 16237333
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["514", "210200"]

Abstract:
Substituted 1,2,3-triazoles as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.

Claim (Index 33):
The method of  claim 30 , wherein the disorder, disease or medical condition mediated by NR2B receptor activity is selected from the group consisting of treatment resistant depression and major depressive disorder.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 98.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15428710', '16046332', '13503231', '14138941', '15725500']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8160733413736531
- 35 USC 102 Novelty (BERT): 0.5949633220718525
- Combined Prediction Score: 0.7939623394434729
- Mean Citation Score: 440.896106
- Max Citation Score: 546.1803
- Similarity Product: 421.6484325085759

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test